Loading
EIF4A2 (Eukaryotic initiation factor 4A-II) is a gene whose normal job is to hold cell growth in check. The public catalogues list it as a tumour suppressor, and it is called a cancer driver by mutation analysis of patient cohorts. Tied to Breast cancer. This dossier gathers the 0 products (0 approved), 0 trials, 0 pathways and 0 resistance routes in the corpus that involve it, with external identifiers so it can be joined to UniProt, ChEMBL, Open Targets and the rest of biology.
ATP-dependent RNA helicase which is a subunit of the eIF4F complex involved in cap recognition and is required for mRNA binding to ribosome. In the current model of translation initiation, eIF4A unwinds RNA secondary structures in the 5'-UTR of mRNAs which is necessary to allow efficient binding of the small ribosomal subunit, and subsequent scanning for the initiator codon. Locus 3q27.3 (HGNC).
No product in the corpus is aimed at this target yet.
No trial in the corpus names this target or one of its products.
No recorded escape route names this target.
No pathway diagram carries this target as a node.
No companion diagnostic in the registry measures this target.
No model entry for this target yet; check the cancer entries on the models page.
No open questions recorded for this target yet. Suggest one.
Query for this target: (TITLE:"EIF4A2" OR ABSTRACT:"EIF4A2" OR TITLE:"eukaryotic translation initiation factor 4A2" OR ABSTRACT:"eukaryotic translation initiation factor 4A2" OR TITLE:"Eukaryotic initiation factor 4A-II" OR ABSTRACT:"Eukaryotic initiation factor 4A-II" OR TITLE:"DDX2B" OR ABSTRACT:"DDX2B" OR TITLE:"EIF4A" OR ABSTRACT:"EIF4A" OR TITLE:"BM-010" OR ABSTRACT:"BM-010") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about EIF4A2, not a curated reading list.
The dossier as machine-readable JSON, at /api/v1/dossiers/eif4a2.json: identifiers from HGNC, Ensembl, UniProt and ChEMBL, products with status, trials, pathways, hotspots, open questions and assays. The full entity record is in the open API at /api/v1/entities/eif4a2.json. Licence CC BY-NC 4.0.